Guidance for Organizations performing in vivo Bioequivalence Note: ANVISA is constantly redesigning its website starting in Aug ANVISA. BRAZILIAN HEALTH REGULATORY AGENCY. Brazilian REPRESENT ADVICE OR GUIDANCE . BIOEQUIVALENCE. Anvisa regulatory guidelines High Impact List of Articles PPts Journals Bioequivalence Journal · Pharmaceutical Analysis Journal · Pharmacovigilance.

Author: Maugami Kajigore
Country: Austria
Language: English (Spanish)
Genre: Environment
Published (Last): 15 July 2015
Pages: 59
PDF File Size: 15.46 Mb
ePub File Size: 3.72 Mb
ISBN: 216-5-52893-600-5
Downloads: 66115
Price: Free* [*Free Regsitration Required]
Uploader: Telkree

Inflammation of a CRO in order to comply with written instructions rather than following common sense.

Pharmaceutical Regulatory Affairs: Open Access

Pharmaceutical Equivalence of Nasal Sprays and Aerosols The Pharmaceutical Equivalence consists in verifying if test drug T complies, integrally, with the specifications of the Pharmacopoeia and with the remaining performance tests as described in the Guidance, and if results obtained are equivalent to the results of reference drug R.

Provides information about alteration, inclusion, suspension, reactivation, cancelation post approval of medicines.

Such techniques are guidleines resistant or robust. The EMA redesigned its website in and Successful approaches implemented internationally could lead to a global alignment in regulatory requirements and would improve the efficacy of topically administered generic formulations.

Accessed 5 May Analysis must be capable of evidencing the identity of the active ingredient in samples of the test and the reference drug product. Plumes generated by actuation of this kind of drug products can be characterized in three stages: Actuations must be conducted in accordance with procedure described in label.

Documents superseded by newer versions are striken through. Disclaimer Although this Collection contains information of a legal nature, it has been developed for informational purposes only and does not constitute legal advice or opinions as to the current operative laws, regulations, or guidelines of any jurisdiction. The space must be proportional to the volume of analysis conduced and to internal organization of lab.

BCS -based Biowaivers; M 9: Each volunteer must receive drug by an individual flask; All volunteers and staff must wear clean area clothing, including caps, masks, and gloves; Before each application, the device must be tested by trained staff and execution of about 5 actuations is recommended, outside the building, on the day prior to the testing day; Flasks must be weighted after 5 actuations and, again, after administration in the volunteers.


Analysis of acidity or alkalinity of a solution. This Resolution shall be in effect on the date of its publication.

Trials employing working guldelines, as long as bioequivslence certification is evidenced, in absence of SQR, shall be admitted. Test must be executed with the vertical, or close to the vertical positioning of flasks.

Editora Atheneu,; – 16 relation on efficacy and safety. Correlation yielded values are between -1 and 1. Volunteers must be previously trained to use the apparatus that will receive the formulation to inhale properly; Before nasal administration 1 minutevolunteers must blow their noses; During nasal application, one of the nostrils must be obstructed while administration is executed in the other nostril.

Received May 21; Accepted Jun Schedule of collection of samples must warrant bioewuivalence characterization of plasmatic profile of drugs, however it must be considerate, besides half-life of elimination, the capability of analytical method to quantify drug by proposed period. Weightings are executed by a scale with proper sensitivity, duly calibrated. Thus, results of the following tests must be submitted: Data and documents generated must be submitted, as well as essay execution SOP.

In addition, because new standards are issued on a continuing basis, this Collection should not be considered an exhaustive source of all current applicable laws, regulations, and guidelines in the field. Another exclusion criteria used for nasal sprays and aerosols is the occurrence of a sneeze two hours after administration of the drug. The bioequivalenve must be executed with the collection of the first delivered dose immediately after priming and the last labeled dose. The environment of lab must have enough room to allow that working areas bioequivalencce kept clean and organized.

Description must follow Brazilian Pharmacopeia; 3.

Global Bioequivalence / Bioavailability Regulatory Guidance Documents §¯`·.¸¸.·´¯`·.¸¸.

Published online Jun According to the Resolution RDC n. National Health Surveillance Agency 1. Exclusions must be documented and justified in Final Report. The continuous gidelines must be monitored and capable of identifying improvement needs. Pharmaceutical Equivalence of Nasal Sprays and Aerosols 3. Though the objective of these drugs is local action, consequences of systemic absorption, such as suppression of the hypothalamus-pituitary-adrenal HPA axismust be taken boequivalence consideration.

In addition, data of two different distances from the laser and the orifice of flasks must be evaluated. Bioequivalence approaches such as in vitro release tests, in vitro skin permeation tests, dermatopharmacokinetic studies, and in vivo pharmacodynamic studies for corticosteroids, which are the most common therapeutic class of topical bioeuivalence drug products in Brazil [ 7 ], may be included as requirements in the future.


However, it is noted that several of these drugs are formulated as a suspensions. Uniformity of Delivered Dose: For that reason, stability of statistical procedures in general must be studied and specifically estimation techniques in presence of deviations from hypothesis which they are based and use techniques that are not very sensitive to these deviations.

Journal of Bioequivalence & Bioavailability

Systemic bioavailability of fluticasone propionate Oficial da Uni? It is recommended a distance of 2 to 7 cm between the laser and the orifice, and that they hold a detachment of 3 cm, or more, between them.

Analysis of the Charge and Recharging data: SinceANVISA has been publishing several Resolutions to establish criteria and requirements to conduct a bioequivalence Trial to register drugs that have been updated along the development of science. The document is an unofficial translation I anfisa at my workshop in Istanbul in March ; I have no guodelines whether anything has changed in the meantime.

Pharmacopoeia Trials to Nasal Sprays and Aerosols 4. It is recommended that time elapsed between first and last actuation does not exceed 1 minute; After last application, volunteers must receive a ml glass of water to conduct particles of drug that might have remained in oral cavity to gastrointestinal tract; Drug must be administered bioequivalece a room, and volunteers must be led to another room where blood samples will be drawn, minimizing the cross-contamination.

In this note, we would like to comment a recently published review article on the similarities and differences among some international jurisdictions in accepting bioequivalence approaches bioequivalencw generic topical dermatological drug products [ 1 ]. The statistical objective is extract valid inferences from a set booequivalence data.

The batches must be submitted in parallel to the essays established in the monograph of the Brazilian Pharmacopoeia or remaining official publications, as per the current Resolutions and the referred Guidance.